Balaxi Pharmaceuticals Limited (BALAXI.NS)
INR 66.96
(-1.18%)
INR 66.96
(-1.18%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 656.74 Million INR | -16.85% |
| 2022 | 792.31 Million INR | 136.65% |
| 2021 | 334.8 Million INR | 99.67% |
| 2020 | 167.68 Million INR | 182.03% |
| 2019 | 59.45 Million INR | 297.98% |
| 2018 | 14.93 Million INR | 102.06% |
| 2017 | 7.39 Million INR | 566.09% |
| 2016 | 1.1 Million INR | -6.42% |
| 2015 | 1.18 Million INR | 47.57% |
| 2014 | 803.8 Thousand INR | 136.82% |
| 2013 | 339.42 Thousand INR | 34.74% |
| 2012 | 251.9 Thousand INR | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q1 | 197.39 Million INR | 12.91% |
| 2023 Q4 | 174.81 Million INR | 1.37% |
| 2023 Q3 | 172.45 Million INR | 11.28% |
| 2023 Q1 | 170.87 Million INR | -5.32% |
| 2023 FY | 658.83 Million INR | -16.85% |
| 2023 Q2 | 154.96 Million INR | -9.31% |
| 2022 Q1 | 180.46 Million INR | 9.82% |
| 2022 FY | 792.31 Million INR | 136.65% |
| 2022 Q4 | 180.46 Million INR | -3.72% |
| 2022 Q3 | 187.43 Million INR | 9.69% |
| 2022 Q2 | 170.87 Million INR | -5.32% |
| 2021 Q3 | 63.25 Million INR | 20.52% |
| 2021 Q2 | 52.48 Million INR | -4.09% |
| 2021 Q4 | 164.33 Million INR | 159.79% |
| 2021 FY | 334.8 Million INR | 99.67% |
| 2021 Q1 | 54.72 Million INR | 64.93% |
| 2020 Q3 | 50.3 Million INR | 10.21% |
| 2020 FY | 167.68 Million INR | 182.03% |
| 2020 Q2 | 45.63 Million INR | 18.27% |
| 2020 Q4 | 33.18 Million INR | -34.04% |
| 2020 Q1 | 38.59 Million INR | 110.0% |
| 2019 Q4 | 18.37 Million INR | 10.84% |
| 2019 Q2 | 15.04 Million INR | 59.23% |
| 2019 Q1 | 9.45 Million INR | 47.92% |
| 2019 FY | 59.45 Million INR | 297.98% |
| 2019 Q3 | 16.57 Million INR | 10.18% |
| 2018 Q1 | 1.3 Million INR | -39.85% |
| 2018 FY | 14.93 Million INR | 102.06% |
| 2018 Q4 | 6.38 Million INR | 17.58% |
| 2018 Q3 | 5.43 Million INR | 199.42% |
| 2018 Q2 | 1.81 Million INR | 39.44% |
| 2017 Q2 | 3.45 Million INR | 422.9% |
| 2017 FY | 7.39 Million INR | 566.09% |
| 2017 Q4 | 2.16 Million INR | 52.14% |
| 2017 Q3 | 1.42 Million INR | -58.85% |
| 2017 Q1 | 660.91 Thousand INR | 46.63% |
| 2016 Q1 | 451.36 Thousand INR | 64.23% |
| 2016 FY | 1.1 Million INR | -6.42% |
| 2016 Q4 | 450.72 Thousand INR | 74.56% |
| 2016 Q3 | 258.21 Thousand INR | 13.75% |
| 2016 Q2 | 227 Thousand INR | -49.71% |
| 2015 Q3 | 514 Thousand INR | 132.82% |
| 2015 Q2 | 220.77 Thousand INR | -3.5% |
| 2015 Q1 | 228.79 Thousand INR | -83.82% |
| 2015 FY | 1.18 Million INR | 47.57% |
| 2015 Q4 | 274.84 Thousand INR | -46.53% |
| 2014 Q3 | -470 Thousand INR | 0.0% |
| 2014 FY | 803.8 Thousand INR | 136.82% |
| 2014 Q4 | 1.41 Million INR | 400.81% |
| 2013 FY | 339.42 Thousand INR | 34.74% |
| 2012 FY | 251.9 Thousand INR | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|